CS238396B2 - Alkpyrimidinone's new derivatives/(bis/aryl/-methylen)-1-piperidinyle)production method - Google Patents
Alkpyrimidinone's new derivatives/(bis/aryl/-methylen)-1-piperidinyle)production method Download PDFInfo
- Publication number
- CS238396B2 CS238396B2 CS837663A CS766383A CS238396B2 CS 238396 B2 CS238396 B2 CS 238396B2 CS 837663 A CS837663 A CS 837663A CS 766383 A CS766383 A CS 766383A CS 238396 B2 CS238396 B2 CS 238396B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- parts
- formula
- mixture
- honors
- straight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43807982A | 1982-11-01 | 1982-11-01 | |
US06/517,612 US4485107A (en) | 1982-11-01 | 1983-07-27 | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
Publications (2)
Publication Number | Publication Date |
---|---|
CS766383A2 CS766383A2 (en) | 1984-12-14 |
CS238396B2 true CS238396B2 (en) | 1985-11-13 |
Family
ID=27031541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS837663A CS238396B2 (en) | 1982-11-01 | 1983-10-19 | Alkpyrimidinone's new derivatives/(bis/aryl/-methylen)-1-piperidinyle)production method |
Country Status (26)
Country | Link |
---|---|
US (1) | US4485107A (bg) |
EP (1) | EP0110435B1 (bg) |
KR (1) | KR870000825B1 (bg) |
AU (1) | AU559176B2 (bg) |
BG (2) | BG51158A3 (bg) |
CA (1) | CA1211438A (bg) |
CS (1) | CS238396B2 (bg) |
CY (1) | CY1607A (bg) |
DE (1) | DE3378825D1 (bg) |
DK (1) | DK168919B1 (bg) |
ES (1) | ES8601965A1 (bg) |
FI (1) | FI77868C (bg) |
GR (1) | GR81277B (bg) |
HK (1) | HK52691A (bg) |
IE (1) | IE56180B1 (bg) |
IL (1) | IL70094A0 (bg) |
IN (1) | IN159576B (bg) |
MA (1) | MA19941A1 (bg) |
NO (1) | NO166133C (bg) |
NZ (1) | NZ205993A (bg) |
PH (1) | PH20483A (bg) |
PT (1) | PT77493B (bg) |
RO (1) | RO86698B (bg) |
SG (1) | SG46791G (bg) |
SU (1) | SU1313349A3 (bg) |
ZW (1) | ZW23283A1 (bg) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4529727A (en) * | 1982-04-21 | 1985-07-16 | Janssen Pharmaceutical, N.V. | Pyrimido[2,1-b][1,3]-thiazines |
US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
US4533665A (en) * | 1983-07-27 | 1985-08-06 | Janssen Pharmaceutica | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
US4888426A (en) * | 1983-11-30 | 1989-12-19 | Janssen Pharmaceutica N.V. | 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine |
US4695569A (en) * | 1983-11-30 | 1987-09-22 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
US4874766A (en) * | 1986-09-22 | 1989-10-17 | Janssen Pharmaceutica N.V. | Method of promoting wound-healing |
US4921854A (en) * | 1986-12-30 | 1990-05-01 | Egis Gyogyszergyar | Condensed thiazolopyrimidine, pyrimido-thiazine or thiazepine pyrimidine compounds |
DE3738844A1 (de) * | 1987-11-16 | 1989-05-24 | Merck Patent Gmbh | Analgetikum |
IL90858A (en) * | 1988-07-07 | 1994-08-26 | Rhone Poulenc Sante | History (Aza) Naftalensultam, their preparation and preparations containing them |
IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
US5158952A (en) * | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
GB8900382D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
US5256659A (en) * | 1989-01-09 | 1993-10-26 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
US5140029A (en) * | 1989-01-09 | 1992-08-18 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
FR2643373B1 (fr) * | 1989-01-10 | 1993-12-31 | Adir Cie | Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
GB9008850D0 (en) * | 1990-04-19 | 1990-06-13 | Janssen Pharmaceutica Nv | Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones |
ES2050069B1 (es) * | 1992-07-10 | 1994-12-16 | Vita Invest Sa | Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona. |
PL314481A1 (en) | 1993-11-19 | 1996-09-16 | Janssen Pharmaceutica Nv | Microencapsulated substituted 3-piperidinyl 1,2-benzoisoxazoles and 1,2-benzoisothiazoles |
ZA979781B (en) * | 1996-11-14 | 1998-06-08 | Akzo Nobel Nv | Piperidine derivatives. |
UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
UA75051C2 (en) | 1999-09-03 | 2006-03-15 | Syngenta Participations Ag | Tetrahydropiridines as pesticides, a composition, a method for the preparation thereof and a method of controlling pests |
TW200400005A (en) * | 2002-02-11 | 2004-01-01 | Syngenta Participations Ag | Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol |
KR20040034996A (ko) * | 2002-10-18 | 2004-04-29 | 한미약품 주식회사 | 리스페리돈의 개선된 제조방법 |
CN100384421C (zh) * | 2002-12-18 | 2008-04-30 | 拜尔农科股份公司 | N-(取代的芳基甲基)-4-(二取代的甲基)哌啶和吡啶 |
WO2004094415A1 (en) * | 2003-04-22 | 2004-11-04 | Synthon B.V. | Risperidone monohydrochloride |
NZ580495A (en) | 2007-04-13 | 2011-05-27 | Southern Res Inst | Use of anti-angiogenic agents and methods of use, particulary amiodarone for inhibiting or reducing angiogenesis |
EP3231793B1 (en) * | 2014-12-12 | 2020-03-11 | Japan Tobacco Inc. | Dihydropyrimidine-2-one compounds and medicinal uses thereof |
PE20210550A1 (es) | 2018-02-28 | 2021-03-17 | Japan Tobacco Inc | Compuestos de 4-metildihidropirimidinona y su uso farmaceutico |
CN112724070B (zh) * | 2021-01-08 | 2022-11-25 | 南京方生和医药科技有限公司 | 一种α,α-二苯基-4-哌啶甲醇的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1252315A (bg) * | 1969-06-05 | 1971-11-03 | ||
US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
DE3000923A1 (de) * | 1979-01-17 | 1980-07-31 | Degussa | Neue n-alkoxy-dithienylpiperidine |
US4342870A (en) * | 1980-03-28 | 1982-08-03 | Janssen Pharmaceutica N.V. | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
-
1983
- 1983-07-27 US US06/517,612 patent/US4485107A/en not_active Expired - Lifetime
- 1983-09-06 IN IN1090/CAL/83A patent/IN159576B/en unknown
- 1983-09-15 CA CA000436799A patent/CA1211438A/en not_active Expired
- 1983-09-29 DE DE8383201393T patent/DE3378825D1/de not_active Expired
- 1983-09-29 EP EP83201393A patent/EP0110435B1/en not_active Expired
- 1983-10-13 PT PT77493A patent/PT77493B/pt not_active IP Right Cessation
- 1983-10-18 NZ NZ205993A patent/NZ205993A/en unknown
- 1983-10-19 CS CS837663A patent/CS238396B2/cs unknown
- 1983-10-21 PH PH29745A patent/PH20483A/en unknown
- 1983-10-27 SU SU833656351A patent/SU1313349A3/ru active
- 1983-10-27 GR GR72809A patent/GR81277B/el unknown
- 1983-10-28 MA MA20161A patent/MA19941A1/fr unknown
- 1983-10-28 ZW ZW232/83A patent/ZW23283A1/xx unknown
- 1983-10-28 IE IE2540/83A patent/IE56180B1/en not_active IP Right Cessation
- 1983-10-28 ES ES526868A patent/ES8601965A1/es not_active Expired
- 1983-10-31 AU AU20834/83A patent/AU559176B2/en not_active Expired
- 1983-10-31 FI FI833995A patent/FI77868C/fi not_active IP Right Cessation
- 1983-10-31 IL IL70094A patent/IL70094A0/xx not_active IP Right Cessation
- 1983-10-31 NO NO833956A patent/NO166133C/no unknown
- 1983-10-31 DK DK498483A patent/DK168919B1/da not_active IP Right Cessation
- 1983-10-31 RO RO112446A patent/RO86698B/ro unknown
- 1983-11-01 BG BG062872A patent/BG51158A3/bg unknown
- 1983-12-30 KR KR1019830004656A patent/KR870000825B1/ko not_active IP Right Cessation
-
1991
- 1991-06-18 SG SG467/91A patent/SG46791G/en unknown
- 1991-07-11 HK HK526/91A patent/HK52691A/xx not_active IP Right Cessation
-
1992
- 1992-04-03 CY CY1607A patent/CY1607A/xx unknown
-
1993
- 1993-06-16 BG BG097874A patent/BG60538B2/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS238396B2 (en) | Alkpyrimidinone's new derivatives/(bis/aryl/-methylen)-1-piperidinyle)production method | |
EP0378255B1 (en) | 2-Aminopyrimidinone derivatives | |
US20090069340A1 (en) | Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders | |
CS256366B2 (en) | Method of new 3-(1-piperidinylalkyl)-4h-pyridol(1,2-pyrimidine-4-on derivatives production | |
KR100730667B1 (ko) | 도파민-d3-수용체 친화성을 갖는 트리아졸 화합물 | |
US4581171A (en) | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders | |
JPH1059961A (ja) | 抗ヒスタミン活性を有する新規ベンズイミダゾール誘導体 | |
CZ291794B6 (cs) | 1-(1,2-Disubstituovaný piperidinyl)-4-substituované deriváty piperazinu, způsob jejich přípravy a použití a farmaceutické kompozice na jejich bázi | |
JPH0794454B2 (ja) | ピラゾロピリジン化合物およびその製造法 | |
HU186952B (en) | Process for preparing condensed pyrimidin-one derivatives | |
KR20150042269A (ko) | N형 칼슘 채널 차단제로서의 치환된 피라졸 | |
WO2011025006A1 (ja) | Gpr119作動薬 | |
JPH04230377A (ja) | 1−インドリルアルキル−4−(アルコキシピリミジニル)ピペラジン | |
CA1246074A (en) | Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines | |
JP3980054B2 (ja) | 抗精神病性の4−(1h−インドリル−1−イル)−1−置換ピペリジン誘導体 | |
PL189549B1 (pl) | Pochodna 1,2,3,4-tetrahydro-benzofuro [3,2-c] pirydyny, jej zastosowanie, kompozycja farmaceutycznai sposób wytwarzania pochodnej 1,2,3,4-tetrahydro-benzofuro [3,2-c] pirydyny | |
US4533665A (en) | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones | |
JPH0480913B2 (bg) | ||
KR101666759B1 (ko) | 1-벤조피란메틸-1h-1,2,3-트리아졸 유도체 및 이의 용도 | |
MXPA06004626A (es) | Indoles sustituidos con piperidina o sus heteroderivados y su uso como moduladores del receptor de quemocina (ccr3). | |
JPS5818390A (ja) | 二環式ピリミジン−5−オン誘導体、その製法および薬効成分としてのその用途 | |
JPH0741481A (ja) | 両性型三環系化合物 | |
AU2015370697A1 (en) | Novel heterocyclic compounds and the use thereof in medicine and in cosmetics |